Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh

被引:124
|
作者
Qadri, Firdausi [1 ]
Wierzba, Thomas F. [3 ]
Ali, Mohammad [3 ,4 ]
Chowdhury, Fahima [1 ]
Khan, Ashraful I. [1 ]
Saha, Amit [1 ]
Khan, Iqbal A. [2 ]
Asaduzzaman, Muhammad [1 ]
Akter, Afroza [1 ]
Khan, Arifuzzaman [1 ]
Begum, Yasmin A. [1 ]
Bhuiyan, Taufiqur R. [1 ]
Khanam, Farhana [1 ]
Chowdhury, Mohiul I. [1 ]
Islam, Taufiqul [1 ]
Chowdhury, Atique I. [1 ]
Rahman, Anisur [1 ]
Siddique, Shah A. [1 ]
Chowdhury, Atique I. [1 ]
Rahman, Anisur [1 ]
Siddique, Shah A. [1 ]
You, Young A. [3 ]
Kim, Deok R. [3 ]
Siddik, Ashraf U. [1 ]
Saha, Nirod C. [1 ]
Kabir, Alamgir [1 ]
Cravioto, Alejandro [3 ]
Desai, Sachin N. [3 ]
Singh, Ajit P. [3 ]
Clemens, John D. [1 ,5 ]
机构
[1] Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh
[2] Inst Epidemiol Dis Control & Res, Dhaka, Bangladesh
[3] Int Vaccine Inst, Seoul, South Korea
[4] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA
[5] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA 90024 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 374卷 / 18期
关键词
O1; DHAKA;
D O I
10.1056/NEJMoa1510330
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND A single-dose regimen of the current killed oral cholera vaccines that have been prequalified by the World Health Organization would make them more attractive for use against endemic and epidemic cholera. We conducted an efficacy trial of a single dose of the killed oral cholera vaccine Shanchol, which is currently given in a two-dose schedule, in an urban area in which cholera is highly endemic. METHODS Nonpregnant residents of Dhaka, Bangladesh, who were 1 year of age or older were randomly assigned to receive a single dose of oral cholera vaccine or oral placebo. The primary outcome was vaccine protective efficacy against culture-confirmed cholera occurring 7 to 180 days after dosing. Prespecified secondary outcomes included protective efficacy against severely dehydrating culture-confirmed cholera during the same interval, against cholera and severe cholera occurring 7 to 90 versus 91 to 180 days after dosing, and against cholera and severe cholera according to age at baseline. RESULTS A total of 101 episodes of cholera, 37 associated with severe dehydration, were detected among the 204,700 persons who received one dose of vaccine or placebo. The vaccine protective efficacy was 40% (95% confidence interval [CI], 11 to 60%; 0.37 cases per 1000 vaccine recipients vs. 0.62 cases per 1000 placebo recipients) against all cholera episodes, 63% (95% CI, 24 to 82%; 0.10 vs. 0.26 cases per 1000 recipients) against severely dehydrating cholera episodes, and 63% (95% CI, -39 to 90%), 56% (95% CI, 16 to 77%), and 16% (95% CI, -49% to 53%) against all cholera episodes among persons vaccinated at the age of 5 to 14 years, 15 or more years, and 1 to 4 years, respectively, although the differences according to age were not significant (P = 0.25). Adverse events occurred at similar frequencies in the two groups. CONCLUSIONS A single dose of the oral cholera vaccine was efficacious in older children (= 5 years of age) and in adults in a setting with a high level of cholera endemicity.
引用
收藏
页码:1723 / 1732
页数:10
相关论文
共 50 条
  • [31] SINGLE-DOSE INACTIVATED HEPATITIS-A VACCINE - RATIONALE AND CLINICAL-ASSESSMENT OF THE SAFETY AND IMMUNOGENICITY
    VANDAMME, P
    THOELEN, S
    MEHEUS, A
    SAFARY, A
    ANDRE, FE
    MATHEI, C
    JOURNAL OF MEDICAL VIROLOGY, 1994, 44 (04) : 435 - 441
  • [32] A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon
    Amani, Adidja
    Tatang, Collins A.
    Bayiha, Christian N.
    Woung, Marcel
    Bama, Solange Ngo
    Nangmo, Armanda
    Mbang, Marie A.
    Douba, Emmanuel Epee
    VACCINE, 2021, 39 (08) : 1290 - 1296
  • [33] SINGLE-DOSE PACKAGING OF MENINGOCOCCAL VACCINE
    MCKINNEY, WP
    BARNAS, GP
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (05): : 638 - 638
  • [34] A SINGLE-DOSE VACCINATION SYSTEM FOR INACTIVATED VETERINARY VACCINES
    BARR, I
    KLEINIG, M
    THIEL, B
    JOURNAL OF LEUKOCYTE BIOLOGY, 1993, : 61 - 61
  • [35] EFFICACY AND SAFETY OF ORAL POLIOVIRUS VACCINE AND INACTIVATED POLIOVIRUS VACCINE
    BEALE, AJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (12) : 970 - 972
  • [36] Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine
    Vadrevu, Krishna Mohan
    Potula, Venugopal
    Khalatkar, Vasant
    Mahantshetty, Niranjana S.
    Shah, Atish
    Ella, Raches
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (09): : 1478 - 1487
  • [37] Studies of the field efficacy and safety of a single-dose Mycoplasma hyopneumoniae vaccine for pigs
    Dawson, A
    Harvey, RE
    Thevasagayam, SJ
    Sherington, J
    Peters, AR
    VETERINARY RECORD, 2002, 151 (18) : 535 - 538
  • [38] Efficacy of single-dose Mycoplasma hyopneumoniae vaccine for the control of enzootic pneumonia in pigs
    Pepovich, Roman
    BULGARIAN JOURNAL OF AGRICULTURAL SCIENCE, 2019, 25 (05): : 1039 - 1043
  • [39] SINGLE-DOSE ORAL TREATMENT OF GONORRHEA
    AMARASURIYA, KL
    ROHATINER, JJ
    GRIMBLE, AS
    BRITISH JOURNAL OF VENEREAL DISEASES, 1974, 50 (01): : 81 - 82
  • [40] SINGLE-DOSE ORAL PHENYTOIN LOADING
    OSBORN, HH
    ZISFEIN, J
    SPARANO, R
    ANNALS OF EMERGENCY MEDICINE, 1987, 16 (04) : 407 - 412